Elliot Norry, Chief Medical Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 24/01/12

Trade details

Type: Insider sale
Amount: $6,629.15
Shares · price: 7,799 sh · $0.85 a share
Held after: 11,841 sh
Stock: Adaptimmune Therapeutics ADAPY
Person: Elliot NorryChief Medical Officer
Trade date: 24/01/12
Filed: 24/01/12
Days to filing: 0 days

Sold 39.7% of holdings

Share of holding sold: 39.7%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/13~24/02/11

Elliot Norry's recent trades

Elliot NorryChief Medical Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,239
5,584 sh
$3,239
Filed 25/01/17
Traded 25/01/17
Elliot NorryChief Medical Officer
Planned saleAdaptimmune Therapeutics
Planned sale
Adaptimmune Therapeutics
ADAPY
$3,243
5,584 sh
$3,243
Filed 25/01/17
Traded 25/01/17
Elliot NorryChief Medical Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$5,588
9,803 sh
$5,588
Filed 25/01/15
Traded 25/01/15
Elliot NorryChief Medical Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$4,793
8,124 sh
$4,793
Filed 25/01/15
Traded 25/01/13
Elliot NorryChief Medical Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2,518
4,268 sh
$2,518
Filed 25/01/15
Traded 25/01/13